Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(261)

92. Software driven biology for small molecule mRNA drugs, Yochi Slonim, Co-founder & CEO, Anima

92. Software driven biology for small molecule mRNA drugs, Yochi Slonim, Co-founder & CEO, Anima

A serial entrepreneur in software and biotech, Yochi Slonim has built multiple companies as a founder and CEO through all phases of growth all the way to IPOs and large M&A exits. As a Co-founder and ...

2 Mar 202240min

91. tRNA therapies, Lovisa Afzelius, Founding CEO, Theonie Anastassiadis, Co-founder & CIO, Alltrna

91. tRNA therapies, Lovisa Afzelius, Founding CEO, Theonie Anastassiadis, Co-founder & CIO, Alltrna

Lovisa Afzelius is an origination partner at Flagship Pioneering and the former SVP of Strategy & Operations at Flagship-founded Cogen Immune Medicines, now known as Repertoire Immune Medicines. A com...

23 Feb 202228min

90. From pharma to founding a biotech, James Mackay, Founder, President & CEO, Aristea Therapeutics

90. From pharma to founding a biotech, James Mackay, Founder, President & CEO, Aristea Therapeutics

James Mackay, PhD, Founder, President and Chief Executive Officer, has over 25 years of development and commercialization expertise in the pharmaceutical industry, including 6 drug product approvals a...

16 Feb 202224min

89. Regenerative medicine pioneer, Laura Niklason, Founder, President, & CEO, Humacyte, Inc.

89. Regenerative medicine pioneer, Laura Niklason, Founder, President, & CEO, Humacyte, Inc.

A physician-scientist, her groundbreaking work in vascular and lung engineering has made Dr. Niklason a world leader in regenerative medicine. She is a member of the National Academies of Engineering ...

9 Feb 202233min

88. Biologics in autoimmune and kidney disease, Marshall Fordyce, CEO and Founder, Vera Therapeutics

88. Biologics in autoimmune and kidney disease, Marshall Fordyce, CEO and Founder, Vera Therapeutics

Dr. Fordyce brings more than 15 years’ experience leading teams in drug discovery, development, clinical translation, and commercialization of new treatments. Before founding Vera, Fordyce was the fo...

2 Feb 202220min

87. Patient-centric Duchenne gene therapy, Joel Schneider, COO, Solid Biosciences

87. Patient-centric Duchenne gene therapy, Joel Schneider, COO, Solid Biosciences

Dr. Schneider is the Chief Operating Officer for Solid Biosciences, responsible for overseeing corporate and technical operations, quality, patient advocacy, communications, corporate strategy, and hu...

26 Jan 202234min

86. Resilient to the core, Trish Hurter, CEO, Jess Ballinger, President & COO, Lyndra Therapeutics

86. Resilient to the core, Trish Hurter, CEO, Jess Ballinger, President & COO, Lyndra Therapeutics

Patricia (Trish) Hurter, Dr. Patricia Hurter is CEO of Lyndra Therapeutics. Prior to Lyndra, Dr. Hurter was Senior Vice President of Pharmaceutical and Preclinical Sciences at Vertex Pharmaceuticals,...

19 Jan 202231min

85. Genomic testing for precision oncology, Shawn Leland, Founder and CEO, Elevation Oncology

85. Genomic testing for precision oncology, Shawn Leland, Founder and CEO, Elevation Oncology

Shawn M. Leland is the Founder and Chief Executive Officer of Elevation Oncology overseeing all day-to-day operations. Shawn brings over a decade of experience in medical affairs and business developm...

12 Jan 202225min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
liberal-halvtime
rekommandert
sinnsyn
smart-forklart
dekodet-2
fjellsportpodden
villmarksliv
rss-nysgjerrige-norge
rss-rekommandert
noen-har-snakket-sammen
rss-paradigmepodden
rss-overskuddsliv
nevropodden
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
vett-og-vitenskap-med-gaute-einevoll
rss-inn-til-kjernen-med-sunniva-rose